Archived Comments for:
Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma
This Article contains typographical errors as follow
1. Figure 2 legend should read
Representative H&E stain (a) and immunohistochemical staining (b–i). Positive stains for p-Akt (b), p-mTOR (c), p-S6RP (d), and p-4EBP (e) in the Akt/mTOR pathway and p-MEK1/2 (g), and p-Erk1/2 (h) in the MAPK pathway. Decreased expression of PTEN in the tumor cells and immunostaining of endothelial cells (f). Immunohistochemical staining with different intensities for HSP90 (i). Immunohistochemically nuclear and/or cytoplasmic staining was judged as positive. Bar: 100 μm
Typographical errors
26 February 2016
This Article contains typographical errors as follow
1. Figure 2 legend should read
Representative H&E stain (a) and immunohistochemical staining (b–i). Positive stains for p-Akt (b), p-mTOR (c), p-S6RP (d), and p-4EBP (e) in the Akt/mTOR pathway and p-MEK1/2 (g), and p-Erk1/2 (h) in the MAPK pathway. Decreased expression of PTEN in the tumor cells and immunostaining of endothelial cells (f). Immunohistochemical staining with different intensities for HSP90 (i). Immunohistochemically nuclear and/or cytoplasmic staining was judged as positive. Bar: 100 μm
2 Additional file 1:Table S1 should read Additional file 2:Table S2
Conversely, Additional file 2:Table S2 should read Additional file 1:Table S1
3 Page2 permission code 25–79 correct to 26-49.
Competing interests
No competing interests exist.